2255-19-8Relevant articles and documents
Butyrylcholinesterase Inhibitors
-
Paragraph 0104; 0105; 0112, (2016/08/17)
Butyrylcholinesterase inhibitors, their formulation, and their use primarily in the treatment of neurodegenerative diseases. These inhibitors generally are phosphates, phosphonates, phosphinates, and phosphoramidates. These inhibitors can be incorporated
Phase transfer catalysed phosphorylation of phenols: Phosphate esters
Batra,Purnanand
, p. 57 - 58 (2007/10/02)
-